Cargando…
Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review)
As the major cause of irreversible loss of vision in adults, diabetic retinopathy (DR) is one of the most serious complications of diabetes. The imbalance of the retinal microenvironment and destruction of the blood-retinal barrier have a significant role in the progression of DR. Inward rectifying...
Autores principales: | Li, Xiaoyu, Lv, Jiajun, Li, Jiazhi, Ren, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343704/ https://www.ncbi.nlm.nih.gov/pubmed/34373707 http://dx.doi.org/10.3892/etm.2021.10453 |
Ejemplares similares
-
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma
por: Decroos, Amandine, et al.
Publicado: (2023) -
Astrocytic Kir4.1 potassium channels as a novel therapeutic target for epilepsy and mood disorders
por: Ohno, Yukihiro
Publicado: (2018) -
Thioredoxin-interacting protein in diabetic retinal neurodegeneration: A novel potential therapeutic target for diabetic retinopathy
por: Liu, Chengzhi, et al.
Publicado: (2022) -
Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes
por: Alex, Alpha, et al.
Publicado: (2020) -
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)